Registry and Monitoring of ImmuNe-mediated Inflammatory Diseases

Registry and Monitoring of ImmuNe-mediated Inflammatory Diseases (IMIDs) REMIND Study

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05172284

Enrollment

2000

Registered

2021-12-29

Start date

2022-02-28

Completion date

2026-12-31

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ImmuNe-Mediated Inflammatory Diseases

Brief summary

Formation of a registry of IMID patients to assess the evolution of resistance to conventional and target therapies. This aim is achieved by evaluating the achievement of PASI 50 and PASI 75 scores at week 16 from the start of treatment.

Interventions

OTHERQuestionnaires

This is a collection of data from normal clinical routine: patients will be asked to record the assessments they undergo during their course of treatment, without changing clinical practice in any way. Data inherent to the following procedures will be collected: examinations, laboratory tests, imaging tests, questionnaires and rating scales.

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients with a diagnosis of IMID. * Patients of any age, including minors. * Patients treated with approved medications for the condition in question and/or phototherapy. * Patients who agree to sign informed consent.

Exclusion criteria

* Patients without a diagnosis of IMID. * Patients who do not consent to sign informed consent.

Design outcomes

Primary

Measure	Time frame	Description
Registry of ImmuNe-mediated inflammatory Diseases (IMIDs)	15 years	Formation of a registry of IMID patients to assess the evolution of resistance to conventional and target therapies.

Secondary

Measure	Time frame	Description
PASI 50	15 years	Assess attainment of PASI 50 score from the start of treatment to all follow-ups
PASI 75	15 years	Assess attainment of PASI 75 score from the start of treatment to all follow-ups

Other

Measure	Time frame	Description
Special populations	15 years	Quantification and monitoring of IMID patients belonging to special populations. Special populations include: homeless, transgender, amputees, para and quadriplegics.

Countries

Italy

Contacts

Primary ContactGiovanni Damiani, Dr.

dr.giovanni.damiani@gmail.com393929403679

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026